Angelia D Gibson. Show Affiliations »
Abstract
Entities: Disease Gene Species
Mesh： See more » Acute DiseaseAdultAgedAntibodies, Monoclonal/adverse effectsAntibodies, Monoclonal/immunologyAntibodies, Monoclonal/therapeutic useAntibodies, Monoclonal, HumanizedAntibodies, Neoplasm/therapeutic useAntigens, CD/immunologyAntigens, Differentiation, Myelomonocytic/immunologyAntineoplastic Combined Chemotherapy Protocols/administration & dosageAntineoplastic Combined Chemotherapy Protocols/adverse effectsAntineoplastic Combined Chemotherapy Protocols/therapeutic useCombined Modality TherapyCytarabine/administration & dosageCytarabine/adverse effectsEtoposide/administration & dosageEtoposide/adverse effectsFever/etiologyHumansHypotension/etiologyInfections/etiologyLeukemia, Myeloid/drug therapyLeukemia, Myeloid/therapyMiddle AgedMitoxantrone/administration & dosageMitoxantrone/adverse effectsRecurrenceRemission InductionSalvage TherapySialic Acid Binding Ig-like Lectin 3Survival RateTreatment Outcome
Substances： See more » Antibodies, MonoclonalAntibodies, Monoclonal, HumanizedAntibodies, NeoplasmAntigens, CDAntigens, Differentiation, MyelomonocyticCD33 protein, humanSialic Acid Binding Ig-like Lectin 3CytarabineEtoposideMitoxantronelintuzumab
Year: 2002 PMID： 12141950 DOI： 10.1016/s1526-9655(11)70245-7
Source DB: PubMed Journal: Clin Lymphoma ISSN： 1526-9655